Platelet aggregation inhibitors/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Chris Day No edit summary |
imported>Chris Day |
||
Line 5: | Line 5: | ||
==Subtopics== | ==Subtopics== | ||
{{r|Aspirin | {{r|Aspirin}} | ||
==Other related topics== | ==Other related topics== | ||
{{r|Anticoagulant}} | {{r|Anticoagulant}} | ||
{{r|Warfarin||**}} | {{r|Warfarin||**}} |
Revision as of 16:22, 27 August 2008
- See also changes related to Platelet aggregation inhibitors, or pages that link to Platelet aggregation inhibitors or to this page or whose text contains "Platelet aggregation inhibitors".
Parent topics
- Platelet activation [r]: Series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue, and release reactions. [e]
Subtopics
- Aspirin [r]: Common analgesic used for treating mild to moderate pain; protective against blood clots and heart disease when administered indefinitely in low doses [e]
- Anticoagulant [r]: Agents that prevent blood clotting. [e]